Anti-malarial medicine capsule and preparation method thereof

An antimalarial drug and capsule technology, applied in the field of antimalarial drug capsules and preparation thereof, can solve the problems of few antimalarial drugs, inability to select antimalarial drugs in a targeted manner, and inability to meet needs, etc. The effect of utilization

Inactive Publication Date: 2013-10-09
海南鑫禾生物工程有限公司
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] There are not many types of capsules used to treat antimalarial drugs on the market, a

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] The present embodiment provides an antimalarial drug capsule, which contains the following ingredients in parts by mass:

[0040] Verbena 20 parts

[0041] Nepeta ears 17 servings

[0042] Salvia 8 servings

[0043] Curcuma 4 parts

[0044] end up hitting 10 copies

[0045] 7 servings of red peony

[0046] Angelica 8 servings

[0047] 3 servings safflower

[0048] 4 parts mulberry leaves

[0049] Yinhua 1 part

[0050] Starch 25 parts

[0051] Sodium carboxymethyl starch 5.8 parts

[0052] Magnesium stearate 1.2 parts.

[0053] A kind of preparation step of antimalarial drug capsule is as follows:

[0054] Step 1: Sieve verbena, nepeta, salvia miltiorrhiza, zedoary, Luodida, red peony, angelica, safflower, mulberry leaves, Yinhua, starch and sodium carboxymethyl starch, and stir them in a blender;

[0055]Step 2: Add sodium carboxymethyl starch solution with a concentration of 5% to the mixer, stir for 30 minutes to make a soft material, pass through a 18-me...

Embodiment 2

[0059] The present embodiment provides an antimalarial drug capsule, which contains the following ingredients in parts by mass:

[0060] Verbena 30 parts

[0061] Nepeta ears 25 parts

[0062] Salvia 13 parts

[0063] Curcuma 10 parts

[0064] End up hitting 15 copies

[0065] 13 servings of red peony

[0066] Angelica 12 servings

[0067] 8 servings of safflower

[0068] 9 parts mulberry leaves

[0069] Yinhua 6 servings

[0070] Starch 44 parts

[0071] Sodium carboxymethyl starch 10 parts

[0072] Magnesium stearate 2 parts.

[0073] A kind of preparation step of antimalarial drug capsule is as follows:

[0074] Step 1: Sieve verbena, nepeta, salvia miltiorrhiza, zedoary, Luodida, red peony, angelica, safflower, mulberry leaves, Yinhua, starch and sodium carboxymethyl starch, and stir them in a blender;

[0075] Step 2: Add sodium carboxymethyl starch solution with a concentration of 5% to the mixer, stir for 30 minutes to make a soft material, pass through a 18...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an anti-malarial medicine capsule and a preparation method thereof. The anti-malarial medicine comprises the following ingredients in parts by mass: 20-30 parts of verbena, 17-25 parts of ching-chieh, 8-13 parts of the root of red-rooted salvia, 4-10 parts of curcuma zedoary, 10-15 parts of centella asiatica, 7-13 parts of radix paeoniae rubra, 8-12 parts of angelica sinensis, 3-8 parts of carthamus tinctorius, 4-9 parts of folium mori, 1-6 parts of grevllia, 25-44 parts of starch, 5.8-10 parts of sodium carboxymethyl starch and 1.2-2 parts of magnesium stearate. The anti-malarial medicine provided by the invention is capable of treating symptoms such as blood heat, vital energy deficiency, meridian symptom acerbity, stasis and impassability, numbness of limbs, skin ulcer caused by muscle heat, and body pain and fatigue, and as the medicine is prepared into capsules, the oral bioavailability can be improved.

Description

technical field [0001] The invention relates to the field of medicines, in particular to an antimalarial drug capsule and a preparation method thereof. Background technique [0002] There are four kinds of protozoa that cause human malaria, namely, Plasmodium vivax, Plasmodium ovale, Plasmodium malariae and Plasmodium falciparum. The life cycle of Plasmodium can be divided into two stages: sexual reproduction and asexual reproduction. The former is carried out in female Anopheles mosquitoes, and the latter is carried out in humans. Asexual reproduction in the human body is divided into primary extraerythrocytic phase, secondary extraerythrocytic phase, and intraerythrocytic phase. Various antimalarial drugs exert their antimalarial effects by affecting different developmental stages of the life cycle of Plasmodium. At present, a large number of countries and regions are endangered by malaria parasites. [0003] There are not many types of capsules used to treat antimalari...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/9066A61K9/48A61P33/06
CPCY02A50/30
Inventor 李建华
Owner 海南鑫禾生物工程有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap